1AD
Asset Logo

Adalta Limited

🇦🇺 ASX

🧬 BIOTECHNOLOGY

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-17.44%
Annual Growth

5 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

AdAlta Ltd. operates as a biotechnology company, discovers, develops, and commercializes protein based therapeutics. The firm uses its i-body platform to discover and develop protein therapeutics addressing drug targets that are challenging for other technologies. The firm's first-in-class lead asset, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases, for which current therapies are sub-optimal. AD-214 is an Fc-Fusion protein that contains two AD-114 i-body molecules at the front end, that bind with high affinity to the human target, CXCR4. The company is also engaged in developing i-body enabled Chimeric antigen receptor T cell (CAR-T) cells. The company co-develops i-bodies as diagnostic imaging agents (i-PET imaging) against Granzyme B, a biomarker of response to immuno-oncology drugs.

📈 Performance

Price History

-92.33%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

0%
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.02

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in 1AD

1

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

17 weeks

💵 Average investment amount

$322

Last time a customer invested in 1AD

84 days
1AD investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

100%

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

100%
🙋 Legal gender of investors

Female

100%

Male

Pearlers who invest in 1AD also invest in...

4Ds Memory Limited

4DS

4DS Memory Ltd. operates as a semiconductor development company. The company is headquartered in Perth, Western Australia. The company went IPO on 2010-12-09. The firm is engaged in the development of a non-volatile memory technology, pioneering Interface Switching resistive random-access memory (ReRAM) for gigabyte storage in mobile and cloud. Interface Switching ReRAM, an area-based ReRAM technology positioned for Storage Class Memory in mobile devices and cloud data centers. The company owns a patented Internet protocol (IP) portfolio, comprising 34 United States patents granted, which has been developed in-house to create high-density storage class memory. The 4DS Interface Switching ReRAM meets the essential requirements for Storage Class Memory close to DRAM. The firm also collaborates with imec, a research and hub in nanoelectronics and digital technologies.

🙌 Performance (5Yr p.a)

1.88%

📊 Share price

$0.07 AUD

🤖 TECHNOLOGY

Find Out More

Alchemy Resources Ltd. engages in the exploration of gold, base metals, and cobalt. The company is headquartered in Perth, Western Australia. The company went IPO on 2007-11-26. Its projects include Lake Rebecca Gold Project, Karonie Project, Lachlan Projects, and Bryah Basin Project. The Karonie Project includes about 16 exploration licenses covering about 1,004 square kilometers of highly prospective mineralized structures within Kurnalpi Terrain greenstones 100 kilometers (km) east of Kalgoorlie. The Lachlan Projects cover an area of about 674 square kilometers of the Central Lachlan Orogen and comprise three project areas prospective for Cobar-style epithermal gold and base metals and copper-gold porphyry mineralization. The Lachlan / Cobar Basin Projects consist of the Overflow Gold-Base Metal Project, the Yellow Mountain Copper-Gold Project, the West Lynn Nickel-Cobalt-Alumina Project and the Eurow Copper-Gold Project. The Bryah Basin Project comprises about 527 square kilometers of ground package.

🙌 Performance (5Yr p.a)

-9.78%

📊 Share price

$0.01 AUD

⛏️ MINING

Armour Energy Ltd. engages in the exploration, development, and production of natural gas and oil resources. The company is headquartered in Brisbane, Queensland and currently employs 34 full-time employees. The company went IPO on 2012-04-26. The firm is in the process of liquidation. The Company’s primary operations have ceased. The firm has some residual assets, such as its investments in Conjugate Energy Limited (UK incorporated company) and Auburn Resources Limited.

🙌 Performance (5Yr p.a)

16.92%

📊 Share price

$0.10 AUD

📈 HIGH PRICE GROWTH

⚡️ ENERGY

Bank of Queensland Ltd. engages in the provision of financial services to the community. The company is headquartered in Brisbane, Queensland and currently employs 3,169 full-time employees. The Company’s operating segments include Retail Banking and BOQ Business. The Retail Banking segment provides retail banking solutions to customers through its owner-managed and corporate branch network, third-party intermediaries, and virgin money distribution channels. Its Owner-Managed Branches retail and small and medium enterprises (SME) lending, deposits, credit cards and insurance. Its VMA business include digital home loans, deposits, credit cards, insurance, and superannuation. The BOQ Business segment includes the BOQ branded commercial lending activity, BOQ Finance and BOQ Specialist businesses. The company also provides tailored business banking solutions, including commercial lending, equipment finance and leasing, cashflow finance, foreign exchange, interest rate hedging, transaction banking and deposit solutions for commercial customers. The company operates more than 160 branches across Australia.

🙌 Performance (5Yr p.a)

-6.23%

📊 Share price

$6.50 AUD

💰 HIGH DIVIDEND

🏦 BANKING

HACK.AX was created on 2016-08-30 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. The fund aims to track the performance of an index (before fees and expenses) that provides exposure to the leading companies in the global cybersecurity sector.

🙌 Performance (5Yr p.a)

13.05%

📊 Share price

$11.65 AUD

📈 HIGH PRICE GROWTH

🤖 TECHNOLOGY

🇦🇺 EX AUSTRALIA

Want more shares? Try these...

Aurora Energy Metals Ltd. engages in the exploration and development of mining properties. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2022-05-18. The AUP is located in Malheur County, Oregon, approximately 16 kilometers (km) northwest of the town of McDermitt, Nevada. The Company’s wholly owned subsidiary, Oregon Energy LLC, holds 100% of the Project as well as surrounding mining claims that extend to the west and to the south-east, across the Oregon/Nevada border. The mining claims are located on public lands in Oregon and Nevada and on a contiguous Company-owned block of private land in Nevada. The land tenure comprises approximately 451 unpatented lode mining claims and 71 unpatented placer mining claims in Malheur County, Oregon and 31 unpatented placer mining claims in Humboldt County, Nevada. The total area covered by these claims is approximately 43 square kilometers. The Project area is covered with a thin veneer of alluvium overlying lakebed sediments.

📊 Share price

$0.04 AUD

⛏️ MINING

Algorae Pharmaceuticals Ltd. is a biotechnology company, which engages in the development of treatments for implanting healthy living cells to replace or repair diseased or damaged organs for life threatening diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-09-01. The firm is focused on discovering and developing novel treatments for medical conditions with under met medical needs. Its programs include AlgoraeOS, Dementia and Parkinson’s. Its drug candidates include NTCELL for Parkinson’s disease and the AI-116 combination drug candidate for dementia. AlgoraeOS is a closed-loop platform, leveraging advanced computational tools to generate novel insights in-silico that are being developed to initiate or accelerate therapeutic programs. The AI-116 is a novel combination drug candidate made up of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The NTCELL is an alginate coated capsule product containing clusters of neonatal porcine choroid plexus cells that are injected into the damaged site within the brain to target the treatment of Parkinson’s disease.

🙌 Performance (5Yr p.a)

-12.22%

📊 Share price

$0.01 AUD

🧬 BIOTECHNOLOGY

1414 Degrees Ltd. engages in the development, design, and manufacture of thermal energy storage systems. SiBox delivers high temperature carbon free industrial heat by harnessing the extremely high latent heat capacity of silicon. This enables intermittent renewables to provide flexible, ultra-high temperature heat 24/7 for industrial applications and to deliver reliable heat and power supply when required. The company is envisaged that the flexibility of the SiBox modular development concept provides a decarbonization pathway for energy users, such as high temperature industrial customers, mineral processing industries, thermal power stations and those needing a combined heat and power solution. The company is also developing the Aurora Energy Project located near Port Augusta, South Australia. The focus of the project is to develop a hybrid renewable energy project delivering reliable electricity to the region and national electricity market.

🙌 Performance (5Yr p.a)

-13.49%

📊 Share price

$0.07 AUD

🔨 COMMERCIAL SERVICES & SUPPLIES

Compare
Add to watchlist